Foz LLC

Chew LLC, based in Boston, MA, is dedicated to transforming the future of food by addressing critical challenges such as access to nutritious meals and the environmental impact of food waste. In a world where 2.37 billion people lack safe food access, the company seeks innovative solutions amidst growing obesity rates and the high failure rate of new consumer products. With an aim to minimize food waste, which contributes significantly to greenhouse gas emissions, Chew LLC advocates for a new paradigm in the food industry, promoting smarter choices in an environment overloaded with options. The firm's commitment to driving change signifies their approach to reshaping how consumers engage with food and nurturing sustainable practices for better health outcomes. Generated from the website

FinePoint Associates LLC, located in Brookline, MA, specializes in consulting, research, and training services focused on economic development and affordable housing. The firm is committed to supporting various projects and services in the areas of economic development (ED) and affordable housing (AH). Under the leadership of Managing Director and CEO Peg Barringer, FinePoint Associates brings a wealth of expertise to its clients. The team is dedicated to delivering impactful solutions that address the unique challenges in their sectors. Generated from the website

BioNTech US Inc, based in Cambridge, MA, is a pioneering global immunotherapy company that focuses on developing innovative treatments aimed at combatting cancer, infectious diseases, and other serious health conditions. With its origins in Mainz, Germany, the company leverages a robust international network and a strong commitment to research and development to advance next-generation immunotherapies. Driven by scientific rigor and operational excellence, BioNTech is dedicated to unlocking the full potential of the immune system and enhancing the health of individuals worldwide. The company continually expands its global manufacturing capabilities to ensure equitable access to its innovative therapies. Generated from the website